Successful treatment of dupilumab‐resistant scaly erythroderma in Netherton syndrome with baricitinib: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful treatment of dupilumab‐resistant scaly erythroderma in Netherton syndrome with baricitinib: A case report

Published:2024-07-05 Issue: Volume: Page:
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:The Journal of Dermatology

Author:

Takegami Tomoya¹^ORCID,Yonekura Satoru¹^ORCID,Nakajima Saeko¹²^ORCID,Kabashima Kenji¹³⁴

Affiliation:

1. Department of Dermatology Kyoto University Graduate School of Medicine Kyoto Japan

2. Department of Drug Discovery for Inflammatory Skin Diseases Kyoto University Graduate School of Medicine Kyoto Japan

3. A*STAR Skin Research Labs (A*SRL), Agency for Science, Technology and Research (A*STAR) Singapore Singapore

4. Skin Research Institute of Singapore (SRIS), Agency for Science, Technology and Research (A*STAR) Singapore Singapore

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.17335

Reference5 articles.

1. A Unique Case of Trichorrhexis Nodosa—"Bamboo Hairs"

2. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome

3. Netherton syndrome: Temporary response to dupilumab

4. Netherton syndrome subtypes share IL-17/IL-36 signature with distinct IFN-α and allergic responses

5. Oral tofacitinib therapy for the effective management of netherton syndrome;Dodeja A;Cureus,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP